Search Results - yuan hong

HOME SEARCH RSS
1 Results Sort By:
Fc receptor targeted and virus-like particle (VLP) based tripartite chimeric vaccine technology
TECH ID 2012-025 Title: Tripartitie Polypeptide Vaccine Vector Current State of the Art: Although traditionally viewed as an anti-infectious preventive measure, vaccine use has expanded to treating non-infectious diseases including cancer. Provenge (Dendreon) is currently the only FDA approved therapeutic vaccine at approximately $95,000 per treatm...
Published: 8/13/2019   |   Inventor(s): Yukai He, David Munn, Yuan Hong
Keywords(s):  
Category(s): Therapeutics
© 2019. All Rights Reserved. Powered by Inteum